v81444
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01634568)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Adenosine A2a receptorANTAGONIST
ADORA2A antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545288 ↗
Also known as
- v81444
- v81444
- v-81444
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02253745 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2013 | Vernalis |
| NCT02764892 | Phase 1 | Aug 1, 2012 | Vernalis |
| NCT01634568 | Phase 1 | Aug 1, 2011 | Hammersmith Medicines Research, Vernalis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vernalis | For profit | 3 | 3 | 2 | 2011 |
| Hammersmith Medicines Research | For profit | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1